Xinqi eye drops: obtained bromine monidine tartaric acid eye drops registration certificate.

Xingqi Eye Medicine announced on April 3rd that today, the company received the "Drug Registration Certificate" issued by the National Medical Products Administration for the approved brimonidine tartrate eye drops. The approved brimonidine tartrate eye drops are a multi-dose product indicated for reducing intraocular pressure in patients with open-angle glaucoma and high eye pressure. As of now, there are already generic versions of the same drug approved and on the market in China.